259 related articles for article (PubMed ID: 23328482)
21. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
23. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
Giannoni P; Cutrona G; Totero D
Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
[TBL] [Abstract][Full Text] [Related]
24. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
25. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
Ringshausen I; Dechow T; Schneller F; Weick K; Oelsner M; Peschel C; Decker T
Leukemia; 2004 Dec; 18(12):1964-70. PubMed ID: 15483673
[TBL] [Abstract][Full Text] [Related]
26. Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.
Barragán M; Campàs C; Bellosillo B; Gil J
Leuk Lymphoma; 2003 Nov; 44(11):1865-70. PubMed ID: 14738137
[TBL] [Abstract][Full Text] [Related]
27. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract][Full Text] [Related]
28. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
[TBL] [Abstract][Full Text] [Related]
29. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CbetaII.
Abrams ST; Lakum T; Lin K; Jones GM; Treweeke AT; Farahani M; Hughes M; Zuzel M; Slupsky JR
Blood; 2007 Feb; 109(3):1193-201. PubMed ID: 17003377
[TBL] [Abstract][Full Text] [Related]
30. HuR Affects Proliferation and Apoptosis of Chronic Lymphocytic Leukemia Cells via NF-
Xiao K; Yang L; Gao X; An Y; Xie W; Jingquan G
Biomed Res Int; 2020; 2020():1481572. PubMed ID: 32908868
[TBL] [Abstract][Full Text] [Related]
31. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
Liu PP; Liu J; Jiang WQ; Carew JS; Ogasawara MA; Pelicano H; Croce CM; Estrov Z; Xu RH; Keating MJ; Huang P
Oncogene; 2016 Oct; 35(43):5663-5673. PubMed ID: 27065330
[TBL] [Abstract][Full Text] [Related]
32. Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
zum Büschenfelde CM; Wagner M; Lutzny G; Oelsner M; Feuerstacke Y; Decker T; Bogner C; Peschel C; Ringshausen I
Leukemia; 2010 Jan; 24(1):141-52. PubMed ID: 19907441
[TBL] [Abstract][Full Text] [Related]
33. B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's.
Krappmann D; Patke A; Heissmeyer V; Scheidereit C
Mol Cell Biol; 2001 Oct; 21(19):6640-50. PubMed ID: 11533251
[TBL] [Abstract][Full Text] [Related]
34. Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.
Nakagawa R; Vukovic M; Tarafdar A; Cosimo E; Dunn K; McCaig AM; Holroyd A; McClanahan F; Ramsay AG; Gribben JG; Michie AM
Haematologica; 2015 Apr; 100(4):499-510. PubMed ID: 25616575
[TBL] [Abstract][Full Text] [Related]
35. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
[TBL] [Abstract][Full Text] [Related]
36. Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia.
Rodriguez CM; Gilardoni MB; Remedi MM; Sastre D; Heller V; Pellizas CG; Donadio AC
Blood Cells Mol Dis; 2020 May; 82():102405. PubMed ID: 32007924
[TBL] [Abstract][Full Text] [Related]
37. Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia.
Handl S; von Heydebrand F; Voelkl S; Oostendorp RAJ; Wilke J; Kremer AN; Mackensen A; Lutzny-Geier G
Leuk Lymphoma; 2021 Nov; 62(11):2679-2689. PubMed ID: 33999745
[TBL] [Abstract][Full Text] [Related]
38. BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber D; Wacht N; Leisch M; Qi Y; Maeding N; Hufnagl C; Jansko B; Zaborsky N; Villunger A; Hartmann TN; Greil R; Egle A
Clin Cancer Res; 2019 Mar; 25(6):1901-1912. PubMed ID: 30487125
[TBL] [Abstract][Full Text] [Related]
39. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]